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INTRODUCTION 
 
Aging is characterized by a gradual decline in various 
health parameters across multiple biochemical, 
physiological and behavioral systems [1]. With 
dysfunction of these systems, quality of life is impaired 
(i.e., reduced healthspan), which ultimately leads to 
death. Interestingly, a subset of aging individuals 
appears to lack resilience within these systems, a 
condition termed frailty. Frailty has broadly been 
defined as an age-associated biological syndrome 
characterized by an exaggerated vulnerability to adverse 
global health outcomes, a reduced capacity to react to 
stressors and an overall loss in physiological function 
[2, 3]. Consequently, frail individuals are at a greater 
risk of falls, dependency, disability, institutionalization, 
hospitalization and mortality [4, 5]. Studying frailty has 
therefore become a pivotal area of research. 
 
Questions in the field of frailty have largely gone 
unanswered due to the inherent limitations of clinical 
studies, including biological, ethical and logistical 
complications of working with older individuals [6, 7]. 
The recent development of assessment tools for frailty 
in mice reverse-translated from human frailty models 
has made it possible to bypass many of these 
aforementioned limitations [8]. For instance, Howlett 
and colleagues [7] established a mouse frailty index 
based on accumulated deficits derived from Rockwood 
et al., [9, 10] that assessed 31 invasive and noninvasive 
variables (i.e., activity levels, hemodynamic measures, 
body composition and basic metabolic status), which 
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ABSTRACT 
 
Many age-related biochemical, physiological and behavioral changes are known to be sex-specific. However, 
how sex influences frailty status and mortality risk in frail rodents has yet to be established. The purpose of this 
study was therefore to characterize sex differences in frail mice across the lifespan. Male (n=29) and female 
(n=27) mice starting at 17 months of age were assessed using a frailty phenotype adjusted according to sex, 
which included body weight, walking speed, strength, endurance and physical activity. Regardless of sex, frail 
mice were phenotypically dysfunctional compared to age-matched non-frail mice, while non-frail females 
generally possessed a higher body fat percentage and were more physically active than non-frail males 
(p≤0.05). The prevalence of frailty was greater in female mice at 26 months of age (p=0.05), but if normalized to 
mean lifespan, no sex differences remained. No differences were detected in the rate of death or mean lifespan 
between frail male and female mice (p≥0.12). In closing, these data indicate that sexual differences exist in 
aging C57BL/6 mice and if the frailty criteria are adjusted according to sex, the prevalence of frailty increases 
across age with frail mice dying early in life, regardless of sex. 
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was later simplified to only include readily apparent 
noninvasive signs of clinical deterioration [11]. 
Similarly, Thompson and colleagues [8] developed a 
frailty phenotype in aged mice that was similar to the 
clinical criteria used by Fried et al., [5] which included 
grip strength, walking speed, physical activity and 
endurance. They recently modified the phenotype to 
also include body weight [12, 13]. The development of 
rodent frailty assessment tools represents an important 
step forward in how we understand frailty, and 
interventions that may delay or prevent its progression.   
 
Recent efforts to understand frailty have extended 
beyond this biological syndrome solely being age-
dependent, but rather age- and sex-dependent. Many 
age-related biochemical, physiological and behavioral 
changes are already known to be sex-specific [14-17], 
which gives credence to the premise that sex may also 
be an important variable associated with frailty status. 
In fact, women have higher frailty index scores than 
men at all ages but paradoxically have a lower mortality 
risk, a concept termed the sex-frailty paradox [18, 19]. 
A phenomenon also known more broadly as the male-
female health-survival paradox; women have poorer 
health than men, characterized by greater burden of 
chronic disease, more disability and worse self-rated 
health, but live longer [20, 21]. These data suggest each 
sex may have different physiological reserves, and that 
the link between health status and mortality is not 
necessarily fixed in humans. To date, very little is 
known regarding sex differences in frail mice or if the 
sex-frailty paradox extends beyond humans. The 
purposes of this study were therefore to characterize sex 
differences in frail C57BL/6 mice across the lifespan 
using a validated frailty phenotype, and assess how 
closely it relates to the human sex-frailty paradox. 
 
RESULTS 
 
A Kaplan-Meier survival analysis revealed male mice 
lived 13% longer than female mice (mean lifespan: 
31.8±0.7 vs. 28.1±0.6 months; p<0.01) (Figure 1).  
To assess sex differences in the prevalence of frailty 
across the lifespan, cut-off values determined at 23 and 
20 months for males and females (Table 1, also see 
‘Frailty criteria’ in the METHODS), respectively, were 
used to categorize mouse frailty from 17 months until 
death [12, 13]. There were more frail female mice at 26 
months than frail male mice (44.4 vs. 73.7%; p=0.05) 
(Figure 2A), however when normalized to the mean 
lifespan for each sex, no differences were detected 
(p≥0.10) (Figure 2B). 
 
Frail mice were then assessed using a Kaplan-Meier 
survival analysis to determine sex differences on 
mortality risk (Figure 3A & B). Frail female mice 
(n=10) had a mean survival time of 26.7±0.8 months, 
which was not different (p=0.12) from the mean 
survival time of 28.7±0.9 months observed in frail male 
mice (n=9) (Figure 3A). There was also no difference 
between mortality rate of frail male and female mice 
when evaluated by survival following the frailty 
assessment (p=0.78) (Figure 3B). See ‘Frailty criteria’ 
in the METHODS for details on the frailty assessment 
components. 
Table 1. Frailty criteria and cut-off values in male and female C57BL/6 mice. 
Human frailty 
phenotype 
Fried et al. [5] 
Mouse frailty  
phenotype Cut-off (%) 
Mouse cut-off values 
Male  
(23 months) 
Baumann et al. [12] 
Female  
(20 months) 
Kwak et al. [13] 
Low activity Voluntary wheel running Lower 20% 1.088 km/day 1.249 km/day 
Poor endurance Treadmill fatigue test Lower 20% 944.2 sec 915.6 sec 
Weakness Grip meter Lower 20% 220.3 g 239.1 g 
Slowness Rotarod test Lower 20% 38.0 sec 27.6 sec 
Lower body weight Body weight Upper 20% 40.6 g 44.1 g 
 
 
 
 
Figure 1. Survival curves of male (n=29) and female (n=27) 
C57BL/6 mice in the original cohort. * Significant difference 
between sex (p≤0.05). 
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To identify if non-frail and frail mice presented 
anthropometrical and/or functional sex differences early 
in life, male and female mice were compared at the time 
of the frailty assessment and three months prior. Frail 
mice, regardless of sex, were heavier (p≤0.05) (Figure 
4A and 5A) and possessed more body fat (p≤0.05) 
(Figure 4B and 5B) than non-frail mice. However, non-
frail and frail female mice had 53.1-62.2% more body 
fat compared to non-frail and frail male mice (p≤0.01) 
(Figure 4B and 5B).  
 
As with body weight and body fat percentage, time to 
fatigue (i.e., endurance, Figure 4E) at the frailty 
assessment and time on the rotarod (i.e., walking speed, 
Figure 5C) in the months prior were less (p≤0.05) for 
frail mice compared to non-frail mice. Frail females 
were weaker than non-frail females (p≤0.05), but both 
were stronger than males at the time of the frailty 
assessment (p≤0.03) (Figure 4D). In the months prior, 
non-frail males had better endurance scores compared 
to non-frail females (p=0.01) (Figure 5E). Physical 
activity measured by voluntary wheel run distance was 
65.2-65.7% greater in non-frail females compared to 
non-frail males, and 127.1-170.8% greater than that of 
frail females (p≤0.01) (Figure 4F and 5F). 
 
DISCUSSION 
 
The purposes of this study were to characterize sex 
differences of frail mice across the lifespan using a 
validated frailty phenotype, and assess how closely it 
relates to the human sex-frailty paradox. Our results 
generated three primary findings. First, the prevalence 
of frailty was greater in female mice but was age- 
 
Figure 2. Prevalence of frailty in male and female mice at each time-point (A) and normalized to the mean lifespan for each respective 
sex (B). The number of frail mice varies by time-point (n=3-18). * Significant difference between sex (p≤0.05). 
 
 
Figure 3. Survival curves of frail male (n=9) and female (n=10) mice. Mice were classified as frail according to the frailty criteria listed in 
Table 1, and survival was assessed across the lifespan (A) and also relative to the time of the frailty assessment (B). 
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Figure 4. Body composition (A, B) and physical function (C-F) of non-frail and frail, male and female mice at the time of the frailty 
assessment. *Significant difference between sex (p≤0.05). #Significant difference between frailty status within sex (i.e., non-frail vs. frail 
male, non-frail vs. frail female) (p≤0.05). Values are presented as mean + standard error. 
 
 
Figure 5. Body composition (A, B) and physical function (C-F) of non-frail and frail, male and female mice three months prior to the 
frailty assessment. *Significant difference between sex (p≤0.05). #Significant difference between frailty status within sex (i.e., non-frail 
vs. frail male, non-frail vs. frail female) (p≤0.05). Values are presented as mean + standard error. 
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dependent, and if normalized to mean lifespan, no sex 
differences remained. Second, frail mice, regardless of 
sex, died at a similar rate after the frailty assessment 
and had comparable mean lifespans. Lastly, 
anthropometrical and functional sex differences impact 
the selection of frailty criteria and determination of cut-
off values. These results do not fully support the sex-
frailty paradox observed in humans, but do suggest that 
regardless of sex, frail C57BL/6 mice are 
anthropometrically and functionally dysfunctional, and 
die early in life [12, 13]. 
 
Women experience greater levels of frailty, which is 
associated with poor health and an increased risk of 
death, but paradoxically live longer than men [18, 19]. 
This phenomenon has been termed the male-female 
health-survival paradox [20, 21], also coined the sex-
frailty paradox [18, 22]. To date, it is currently 
unknown if this paradox extends to common rodent 
models (e.g., C57BL/6 mice) used to study frailty and 
aging. For comparison between human and rodents, we 
have outlined the sex-frailty paradox into two 
components: 1) the prevalence of frailty and 2) the 
mortality risk of those identified as frail. 
 
The first component of the sex-frailty paradox in 
humans is that frailty scores are greater in women. In 
the laboratory, this component has not been fully 
established in mice. In fact, some report no sex 
differences [7, 23] while others report greater frailty 
scores in female C57BL/6 mice [11], and more recently 
in female NIH Swiss mice [24]. Our data partially 
support the latter findings that female mice exhibit 
greater levels of frailty, though it was age-dependent 
and only transient. Using a longitudinal lifespan study 
design with a phenotypic frailty assessment tool, we 
observed that at 26 months of age the prevalence of 
frailty was 66.0% greater in females than males (73.7 
vs. 44.4%), however no differences were detected at 
any other age (Figure 2A). Furthermore, the prevalence 
of frailty in males increased to a similar extent from 26 
to 29 months as that seen in females from 23 to 26 
months. Aging female NIH Swiss mice also experience 
a sharp increase in frailty scores beyond that of males 
when assessed using a physiological frailty index [24]. 
It is possible that these observations [present study, 24] 
are linked to hormones, immune function or regional 
distribution of body fat, factors associated with sex 
differences in response to life-extending genetic or 
pharmacological interventions [25]. Together, these 
data partially support that the prevalence of frailty is 
greater in females but is likely age-dependent, as all 
mice (regardless of sex) eventually become frail. 
 
The observation that female mice have greater frailty 
scores or prevalence of frailty is not a certainty and with 
further interpretation, can be challenged. Indeed, in the 
present study male mice lived 13% longer than female 
mice (Figure 1). Several other groups have shown 
C57BL/6 male mice live longer than female mice, though 
there is a fair amount of variability [26, 27]. Austad and 
Fischer [28] recently reviewed 29 studies on the C57BL/6 
mouse strain and found that males lived longer in 18 
studies and females lived longer in 11 studies. Therefore, 
it is critical researchers consider sex differences in 
lifespan and make the proper adjustments to their frailty 
scores and cut-off values. In the present study, frailty cut-
off values were selected at different time-points based on 
the 3.7-month variance in mean lifespan between sex, 
with frailty determination occurring at 23 and 20 months 
for male and female mice, respectively (Table 1). Taking 
this rationale a step further, we normalized the prevalence 
of frailty in male and female mice to the mean lifespan for 
each sex, which therefore takes into account the three 
month offset previously mentioned (i.e., 23 vs. 20 
months). Using this approach, the sex difference observed 
in the prevalence of frailty was eliminated, indicating that 
the prevalence of frailty was similar between male and 
female C57BL/6 mice (Figure 2B). These results and their 
subsequent interpretations suggest that sex differences in 
lifespan be taken into account when comparing male and 
female rodents. 
 
The second component of the sex-frailty paradox is that 
women live longer than men despite having higher 
frailty scores [18, 19]. Our data does indicate that at one 
time-point (without normalization to the mean lifespan), 
the prevalence of frailty was greater in females (Figure 
2A). However, when assessing mortality risk of frail 
mice across sex, we did not observe that frail female 
mice lived any longer. In fact, regardless of sex, frail 
mice died at a similar rate following the frailty 
assessment at 23 and 20 months for male and female 
mice, respectively (Figure 3A & 3B). Approximately 
50% of the frail male and female mice died within six 
months after being identified as frail (Figure 3B). Our 
data suggest frail male and female C57BL/6 mice die at 
a similar rate when frailty cut-off values are adjusted to 
reflect variability in sex and lifespan. Overall, in our 
cohort of aging C57BL/6 mice, it appears frail females 
do not paradoxically live longer than frail males; and 
therefore, does not support the second component of the 
sex-frailty paradox observed in humans.  
 
After determining the prevalence of frailty and overall 
mortality risk did not appear to have prominent sex 
differences, we turned to examining sex-specific 
characteristics used in the frailty assessment tool. Kane 
et al. [29] recently articulated the concept that, “there 
are different ways to become frail and each of them is 
valid for the person or mouse who becomes frail in that 
way,” a concept we explored further and assessed 
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whether it was also sex-specific. Our results indicate 
that although some frailty markers were similar between 
sex, others appeared to be dependent on being male or 
female. For instance, non-frail female mice were more 
physically active than non-frail males, a common sex 
difference observed in mice [30, 31]. It is therefore 
important to acknowledge that some sex differences 
will be present when determining frailty criteria and 
cut-off values. The observation that non-frail females 
ran ~65% further on the voluntary wheels than non-frail 
males is a prime example of a functional sex difference 
(Figure 4F & 5F), and solid justification that frailty cut-
off values cannot simply be applied across sex. Fried’s 
human phenotype [5] acknowledged this by using cut-
off percentiles according to gender and Antoch et al. 
[24] alluded to this in mice, by reporting parameters of 
their physiological frailty assessment, which only 
showed partial overlap between males and females. We 
suggest that sex differences be considered when 
assessing frailty, and emphasize that there are different 
ways to become frail – one of which may be sex. 
 
In closing, using a longitudinal lifespan study design we 
characterized sex differences in frail C57BL/6 mice via 
a validated frailty phenotype, and compared our 
findings to that of the sex-frailty paradox observed in 
humans. Our results suggest phenotypic sex differences 
exist in C57BL/6 mice and that males live longer than 
females. Researchers should therefore be cognizant of 
the anthropometrical, functional and lifespan 
differences between males and females, and adjust 
frailty criteria based on sex and mean lifespan – as done 
in the present study. Despite these sex differences, the 
prevalence of frailty was generally the same between 
sexes, with the exception of a single age when frailty 
was greater in females.  Moreover, after a mouse was 
identified as frail, male and female mice died at a 
similar rate. Together, these results (i.e., in C57BL/6 
mice) do not fully support the sex-frailty paradox 
observed in humans. In closing, these data indicate that 
sex differences exist in aging C57BL/6 mice and if the 
frailty criteria are adjusted accordingly, the prevalence 
of frailty increases across age with frail mice dying 
early in life [12, 13], regardless of sex. 
 
METHODS 
 
Ethical approval and animals 
 
Male (n=29) [12] and female (n=27) [13] C57BL/6 
mice were purchased from Jackson Laboratory (Bar 
Harbor, ME, USA) at 13 and 5 months, respectively. 
Mice were housed under a 12 hour light:dark cycle at 
20-23oC in specific pathogen-free facilities, supplied 
with food and water ad libitum, and allowed to age and 
die of natural causes. All animal procedures were in 
accordance with the standards set by the Institutional 
Animal Care and Use Committees at the University of 
Minnesota and Boston University. 
 
Experimental design 
 
Testing was initiated at 17 months of age and continued 
every 3 months (20, 23,... 32 or death) making this 
study a repeated measures research design, which 
allowed us to determine the lifespan of each individual 
mouse. For each performance testing period, mice were 
subjected to a battery of assessments over a one-week 
period during every three-month interval, as previously 
used by Thompson and colleagues [12, 13]. All testing 
procedures followed the same protocol during each 
assessment, and to ensure testing reliability, all 
assessments were completed by the same testers. 
 
Body weight and body fat percentage 
 
Body weights were obtained on an electronic scale (CS-
200, Ohaus, Parsippany, NJ, USA), while body fat 
percentage was evaluated using a Lunar PIXImus 
densitometer (GE Lunar Corporation, Madison, WI, 
USA). Briefly, a phantom mouse was first used as a 
calibration standard for quality control prior to each 
testing day. Mice were then anesthetized with 
isoflurane, placed on an adhesive specimen tray, and 
scanned with the skull excluded and tail included. 
 
Walking speed 
 
Walking speed was evaluated using a rotarod (Rota-Rod 
R/S; LSi Letica, Cornella, Spain). Mice were first 
warmed-up on the rotarod by walking at 4 rpm for 30 
seconds, at which point rotarod speed increased 1 rpm 
every 8 seconds up to 40 rpm over a 5 min period. 
Walking speed was recorded when the mouse was 
unable to sustain the rotation speed of the rotarod. Each 
mouse performed three trials with a 10-minute rest 
period in-between each trial. The best score of these 
trials, recorded as seconds, was used as walking speed. 
 
Strength 
 
Strength was evaluated using a grip meter test 
(P/N760483, Coulbourn Instruments, Whitehall PA). 
Mice were gently lowered over the top of a wire grid so 
that the front and hind paws gripped the grid. Once 
gripped, the tail of each mouse was pulled back 
steadily, keeping the mouse’s torso in a horizontal 
position. When the mouse was unable to maintain its 
grip, the trial was over and the grip strength, in grams, 
was recorded. Each mouse performed two trials with a 
10-minute rest period in-between each trial. The best 
score of these trials was used as peak grip strength. 
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Endurance 
 
Endurance was evaluated using a time to fatigue test on 
a motorized treadmill (Exer 3/6 Treadmill; Columbus 
Instruments, Columbus, OH). After a brief warm-up (5 
m/min for 5 min), mice remained on the treadmill and 
time to fatigue began with speed increasing 1 m/min 
every minute. Motivation was provided by gently 
tapping the mouse’s rear [12, 13, 32]. Time to fatigue 
was recorded following the third time the mouse could 
no longer keep pace with the speed of the treadmill. 
Endurance was determined to be the total amount of 
time, in seconds, the mouse remained on the treadmill. 
 
Physical activity 
 
Physical activity was evaluated by assessing voluntary 
distance ran using a running wheel (Model number: 
80820F, Lafayette Instruments, Lafayette, IN). Briefly, 
mice were individually housed in the wheel running 
cages for four days. The running distance, in 
revolutions, was recorded and converted to kilometer. 
The average distance ran per day was used to score 
physical activity. 
 
Frailty criteria 
 
Following the percentiles used by Fried et al. [5], mice 
that fell in the bottom 20% for walking speed, strength, 
endurance and physical activity were considered to have 
a positive frailty marker (i.e., for that give criteria) [12, 
13]. However, rather than unintentional weight loss, we 
determined that mice with a high body weight, in which 
they weighed in the top 20% to be positive for this 
frailty criterion (i.e., body weight). A detailed rationale 
for selecting heavy or overweight mice as a positive 
marker for frailty can be found in Baumann et al. [12]. 
Criteria were used to identify frailty cut-off values at 23 
and 20 months of age for male and female mice, 
respectively. These ages were selected for several 
reasons. First, male mice lived 3.7 months longer than 
female mice (Figure 1). Second, these ages represent a 
high survival rate; meaning they are near the maximal 
age before mice begin dying, making it an optimal age to 
predict frailty. Third, 20 to 23 months for a mouse are 
equal to approximately 60 to 75 human years [5, 10], 
which correspond to the initial age brackets assessed by 
Fried et al. [5]. Lastly, because frailty is thought to be 
reversible [33, 34], this age provides adequate time to 
implement possible life changing interventions. 
 
In our previous publications [12, 13], mice were 
categorized into three distinct groups (e.g., non-frail, 
pre-frail and frail) based on the number of positive 
frailty markers they possessed. However, because we 
did not detect differences in the lifespan of pre-frail and 
frail female mice, we combined these two groups in the 
study by Kwak et al. [13]. Therefore, for the purpose of 
this study, male and female mice were categorized into 
two distinct groups: mice with two or more positive 
frailty markers were identified as frail while mice with 
one or no positive frailty marker were considered non-
frail. Table 1 lists cut-off values and the ages (23 and 20 
months for male and female mice, respectively) that 
were used to quantify the prevalence of frailty for all 
other age groups (i.e., from 17 months until death). 
 
Statistical analysis 
 
A Kaplan-Meier analysis was performed to assess the 
sex differences in lifespan. In order to account for 
variability in lifespan between male and female mice 
(Figure 1), the prevalence of frailty was also assessed 
relative to the mean lifespan for each respective sex. 
Differences in prevalence of frailty, and 
anthropometrical and functional sex characteristics were 
examined using an independent t-test. Values are 
presented as mean ± standard error. Statistical 
significance was defined as p≤0.05. Data analyses were 
completed using SPSS 24.0 (IBM Corp, Armonk, NY) 
or SigmaPlot 14.0 (Systat Software Inc., Point 
Richmond, CA).  
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